Literature DB >> 1356987

Characterization of dynorphin A-converting enzyme in human spinal cord. An endoprotease related to a distinct conversion pathway for the opioid heptadecapeptide?

J Silberring1, M E Castello, F Nyberg.   

Abstract

A highly specific proteinase, converting dynorphin A (1-17) to enkephalins, was isolated from the human spinal cord and subjected to further characterization. The enzyme was found to be a thiol-dependent protein with a relative molecular mass of 50 kDa and a pH optimum between 5.0 and 5.5. This proteinase appears to exclusively convert dynorphin A (1-17) to Leu-enkephalin and its COOH-terminal extensions Leu-enkephalin-Arg6 (which was a major conversion product) and Leu-enkephalin-Arg6-Arg7 but not the other prodynorphin- or proenkephalin-derived peptides. This high specificity toward a single structure is suggested to be involved in a distinct processing pathway associated with the generation of the opioid peptides with selectivity for delta-opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23.

Authors:  Georgy Bakalkin; Hiroyuki Watanabe; Justyna Jezierska; Cloë Depoorter; Corien Verschuuren-Bemelmans; Igor Bazov; Konstantin A Artemenko; Tatjana Yakovleva; Dennis Dooijes; Bart P C Van de Warrenburg; Roman A Zubarev; Berry Kremer; Pamela E Knapp; Kurt F Hauser; Cisca Wijmenga; Fred Nyberg; Richard J Sinke; Dineke S Verbeek
Journal:  Am J Hum Genet       Date:  2010-10-28       Impact factor: 11.025

2.  Regional quantitation of preprodynorphin mRNA in guinea pig gastrointestinal tract.

Authors:  V P Yuferov; J A Culpepper-Morgan; K S LaForge; A Ho; M J Kreek
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

3.  Evaluation of an on-capillary copper complexation methodology for the investigation of in vitro metabolism of dynorphin A 1-17.

Authors:  Courtney D Kuhnline; Susan M Lunte
Journal:  J Sep Sci       Date:  2010-08       Impact factor: 3.645

4.  Dynorphin peptides differentially regulate the human kappa opioid receptor.

Authors:  Yong Chen; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2007-01-20       Impact factor: 5.037

Review 5.  Sex differences in opioid receptor mediated effects: Role of androgens.

Authors:  Jessica L Sharp; Tallia Pearson; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2022-01-04       Impact factor: 8.989

6.  Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat.

Authors:  Junko Ajimi; Masanobu Yoshikawa; Shigeru Takahashi; Masaaki Miura; Hideo Tsukamoto; Mitsuru Kawaguchi; Hiroyuki Kobayashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2014-06-19       Impact factor: 2.078

7.  β-Neoendorphin Enhances Wound Healing by Promoting Cell Migration in Keratinocyte.

Authors:  Dong Joo Yang; Sang Hyun Moh; Yun-Hee Choi; Ki Woo Kim
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.